Small Bone Innovations, Inc. to Conduct Limb Salvage Workshop at Annual Diabetic Foot Conference in Los Angeles

Wed Mar 18, 2009 3:09pm EDT

* Reuters is not responsible for the content in this press release.

* SBi is a provider of products & education services to Foot & Ankle surgeons
treating diabetic feet
* Technology helps reduce number of lower limb amputations
* Annual global Diabetic Foot Conference (DF Con 09) with 800 delegates

NEW YORK--(Business Wire)--
Small Bone Innovations, Inc. (SBi), a single-source provider of innovation,
products, technology and education for the small bone & joint sector, is staging
a limb salvage technology workshop tomorrow at the annual Diabetic Limb
Conference (DF Con 09) at the Renaissance Hotel, Los Angeles, CA. 

SBi is providing an educational grant for a workshop on March 19th entitled
Essentials of Circular Fixation for the Treatment of Charcot Deformity and
Damage Control Orthopedics. The workshop is chaired by Dr. Dane K. Wukich, MD,
Chief of Foot & Ankle Surgery, Department of Orthopaedics, at the University of
Pittsburgh Medical Center. SBi expects over 50 attendees at the workshop. 

A wide spectrum of generalists and specialists from around the world who
diagnose and manage the diabetic foot are being offered a hands-on opportunity
to study the techniques in diabetic foot salvage based on the pioneering work of
Professor Gavriil A. Ilizarov. 

In addition to workshops in the U.S., SBi also sponsors week-long programs at
the Russian Ilizarov Scientific Center for Restorative Traumatology and
Orthopedics in Kurgan, Siberia. The Center is the largest in the world
specializing in treatment of complex orthopedic problems and best known for its
practice and teaching of TheIlizarov Method. To date, more than 60 U.S. Foot &
Ankle surgeons have enhanced their skills in limb salvage procedures through the
SBi program. 

SBi offers a range of lower limb, external fixation products under its RingFIX
brand that utilizes these techniques. The RingFIX system is used extensively in
the U.S. by Foot & Ankle surgeons, including specialists at a growing number of
limb salvage centers catering to patients suffering from a condition known as
Charcot Foot. Patients with advanced cases of Charcot Foot are at a high risk
for amputation. 

Anthony G. Viscogliosi, Chairman & CEO of SBi, said: "It is very encouraging to
have the opportunity to bring vital, often life-changing technology to surgeons
attending the annual DF Con event. It reflects our value creation thesis of
being data-driven, surgeon-centric and patient focused in addressing unmet
clinical needs in orthopedics." 

The total annual economic cost of diabetes in 2007 was estimated to be $174
billion in the U.S. Medical expenditures totaled $116 billion and were comprised
of $27 billion for diabetes care, $58 billion for chronic diabetes-related
complications, and $31 billion for excess general medical costs, according to
statistics published by the American Diabetes Association. 

Founder and Co-chair of DF Con 09, David G. Armstrong, DPM, PhD, Professor of
Surgery and Director of the Southern Arizona Limb Salvage Alliance (SALSA)
University of Arizona College of Medicine, said: "Every 30 seconds, a limb is
lost somewhere in the world due to diabetes. Surgeons must have every weapon in
their arsenal to stem this tsunami. For this reason, it is heartening to see
unique labs and workshops like the SBi program providing training that will no
doubt go a long way to saving limbs and improving the lives of our patients with
diabetes." 

SBi`s President, Thomas A. Crowley, Jr., noted: "Surgeons believe that a
significant proportion of the more than 70,000 non-traumatic lower limb
amputations performed in the U.S. each year could be eliminated through early
detection of Charcot Foot and subsequent use of external fixation systems." 

Scott Ludecker, Vice President of SBi`s Worldwide Diabetes & Limb Preservation
Systems, added: "I am pleased to bring together a world class faculty this week
to provide an unprecedented educational opportunity for physicians who care for
diabetic patients. Given the exponential worldwide growth in diabetes and the
complications that follow, our educational and product-related contributions to
limb salvage techniques are making a difference in these patients` lives every
day." 

DF Con 09 is being sponsored by Providence Saint Joseph Medical Center, Burbank,
CA and is expected to attract more than 800 delegates from the U.S. and 50 other
countries. The annual meeting serves as a premier gathering place for
disseminating new research and practical knowledge on diabetic foot issues and
on the fight against diabetes-related amputations. 

About Small Bone Innovations, Inc.

Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi Brothers,
LLC, (VB), a New York-based merchant banking firm that specializes in the
musculoskeletal/orthopedics sector. VB created SBi as the first company to focus
purely on small bones & joints. By integrating established companies and
professionals in the field, SBi offers a broad, clinically proven portfolio of
products and technologies to treat trauma and diseases in small bones & joints.
Today, SBi has more than 130 employees at facilities in New York, NY,
Morrisville, PA, Bourg-en-Bresse, France and Donaueschingen, Germany, among
other locations worldwide. 

For more information on SBi, please visit: www.totalsmallbone.com. 

About Viscogliosi Bros., LLC

Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G.
Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB) was the first
venture capital/private equity and merchant banking firm dedicated exclusively
to the musculoskeletal/orthopedics sector of the health care industry. As
principals of VB, the Viscogliosi brothers have a combined total of nearly half
a century of experience analyzing and investing in the
musculoskeletal/orthopedics sector. 

VB`s mission is to create, build and finance companies founded on innovations
developed by surgeons and uniquely focused on "life changing"
musculoskeletal/orthopedic technologies. VB has worldwide surgeon, industry and
trade relationships, and significant financial expertise in the
musculoskeletal/orthopedic sector. The Viscogliosi brothers have pioneered more
than 170 financial, strategic and management initiatives for companies in the
musculoskeletal/orthopedic sector, from start-up, seed and development stage all
the way to exit. These initiatives have helped people live better lives through
the orthopedic and spinal products developed, marketed and sold by the companies
VB has assisted in developing and financing. 

For more information about VB, please visit: www.vbllc.com. 

Forward-looking statements

This press release contains forward-looking statements as defined in the U.S.
Private Securities Litigation Reform Act of 1995.Readers are cautioned not to
place undue reliance on these forward-looking statements. Actual results may
differ materially from those indicated by these forward-looking statements as a
result of risks and uncertainties impacting SBi`s business including increased
competition; the ability of SBi to expand its operations andto attract and
retain qualified professionals; technological obsolescence; general economic
conditions; and other risks.





Small Bone Innovations, Inc.
Anthony Viscogliosi, 212-583-0370 ext. 2100
aviscogliosi@totalsmallbone.com
or
Creative Partners, LLC
Nick Kilsby, 203-705-9202
nkilsby@creativepartners.com



Copyright Business Wire 2009